- Report
- October 2022
- 310 Pages
Global
From €2484EUR$2,688USD£2,094GBP
€3549EUR$3,840USD£2,992GBP
- Report
- February 2022
- 311 Pages
Global
From €2401EUR$2,598USD£2,024GBP
€3431EUR$3,712USD£2,892GBP
- Report
- December 2021
- 170 Pages
Global
From €2401EUR$2,598USD£2,024GBP
€3431EUR$3,712USD£2,892GBP
- Report
- June 2021
- 287 Pages
Global
From €2401EUR$2,598USD£2,024GBP
€3431EUR$3,712USD£2,892GBP
- Report
- October 2023
- 428 Pages
Global
From €2310EUR$2,499USD£1,947GBP
€3299EUR$3,570USD£2,781GBP
- Report
- April 2023
- 249 Pages
Global
From €2310EUR$2,499USD£1,947GBP
€3299EUR$3,570USD£2,781GBP
- Report
- March 2023
- 280 Pages
Global
From €2310EUR$2,499USD£1,947GBP
€3299EUR$3,570USD£2,781GBP
- Report
- January 2023
- 256 Pages
Global
From €2310EUR$2,499USD£1,947GBP
€3299EUR$3,570USD£2,781GBP
- Report
- August 2022
- 322 Pages
Global
From €2310EUR$2,499USD£1,947GBP
€3299EUR$3,570USD£2,781GBP
- Report
- July 2022
- 315 Pages
Global
From €2484EUR$2,688USD£2,094GBP
€3549EUR$3,840USD£2,992GBP
- Report
- June 2022
- 297 Pages
Global
From €2236EUR$2,419USD£1,885GBP
€3194EUR$3,456USD£2,693GBP
- Report
- April 2022
- 262 Pages
Global
From €2236EUR$2,419USD£1,885GBP
€3194EUR$3,456USD£2,693GBP
- Book
- September 2024
- 304 Pages
- Book
- September 2023
- 272 Pages
- Book
- March 2022
- 896 Pages
- Book
- January 2022
- 336 Pages
- Book
- December 2020
- 432 Pages
- Book
- March 2020
- 160 Pages
- Book
- January 2013
- 288 Pages

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more